Infinity Stock Financials


USD 0.59  0.04  6.35%   

Infinity Pharmaceuti Average Equity is most likely to decrease significantly in the upcoming years. The last year's value of Average Equity was reported at 36.83 Million. The current Enterprise Value is estimated to increase to about 114.2 M, while Net Income Per Employee is projected to decrease to (1.5 M).
With this module, you can analyze Infinity financials for your investing period. You should be able to track the changes in Infinity Pharmaceuti individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Infinity Most Recent Estimates

Diluted Eps
EPS Estimate Current Year
EPS Estimate Next Year
EPS Estimate Current Quarter
Earnings Share


1.91 Million

Understanding current and past Infinity Pharmaceuti Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Infinity Pharmaceuti's financial statements are interrelated, with each one affecting the others. For example, an increase in Infinity Pharmaceuti's assets may result in an increase in income on the income statement.
The fundamental analysis of Infinity Pharmaceuti is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Infinity Pharmaceuti includes many different criteria found on its balance sheet. For example, investors should never minimize Infinity Pharmaceuti's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Infinity Pharmaceuti's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Infinity Pharmaceuti.

Infinity Pharmaceuti Cash

Chance Of Financial Distress
Less than 6
Infinity Pharmaceuti has less than 6 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Infinity Pharmaceuti stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Infinity Pharmaceuti's official financial statements usually reflect Infinity Pharmaceuti's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Infinity Pharmaceuti. For example, before you start analyzing numbers published by Infinity accountants, it's critical to develop an understanding of what Infinity Pharmaceuti's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Infinity Pharmaceuti's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Infinity Pharmaceuti's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Infinity Pharmaceuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Infinity Pharmaceuti. Please utilize our Beneish M Score to check the likelihood of Infinity Pharmaceuti's management to manipulate its earnings.

Infinity Pharmaceuti Company Summary

Infinity Pharmaceuti competes with 3M. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001113148
Older SymbolDPII
RegionNorth America
LocationMassachusetts; U.S.A
Business Address1100 Massachusetts Avenue,
Phone617 453 1000
CurrencyUSD - US Dollar
You should never invest in Infinity Pharmaceuti without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Infinity Stock, because this is throwing your money away. Analyzing the key information contained in Infinity Pharmaceuti's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Infinity Pharmaceuti Key Financial Ratios

Generally speaking, Infinity Pharmaceuti's financial ratios allow both analysts and investors to convert raw data from Infinity Pharmaceuti's financial statements into concise, actionable information that can be used to evaluate the performance of Infinity Pharmaceuti over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Infinity Pharmaceuti reports annually and quarterly.

Infinity Pharmaceuti Key Balance Sheet Accounts

201720182019202020212022 (projected)
Accounts Payable459 K1.2 M1.62 M2.98 M2.32 M3.33 M
Total Assets59.35 M60.22 M49.01 M39.32 M84.78 M112.27 M
Current Assets58.39 M59.82 M44.58 M36.02 M82.27 M106.64 M
Assets Non Current967 K397 K4.43 M3.3 M2.52 M2.58 M
Cash and Equivalents34.61 M48.62 M22.26 M28.59 M80.73 M83.01 M
Total Debt19.59 M6 M1.93 M1.44 M917 K941.13 K
Shareholders Equity47.73 M52.46 M7.73 M(22.99 M)21.57 M22.14 M
Investments23 M9.97 M20.5 M5.68 M158 K162.16 K
Investments Current23 M9.97 M20.18 M5.51 M4.96 M5.09 M
Total Liabilities11.62 M7.76 M41.29 M62.31 M63.21 M61.72 M
Current Liabilities11.6 M7.72 M9.7 M11.05 M13.3 M17.41 M

Infinity Pharmaceuti Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Infinity Pharmaceuti's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201720182019202020212022 (projected)
Consolidated Income(41.83 M)(11.25 M)(47.06 M)(40.49 M)(45.26 M)(48.84 M)
Gross Profit6 M22.15 M3.05 M1.72 M1.86 M1.91 M
Interest Expense1.01 M93 K2.56 M2.44 M180 K184.74 K
Net Income(41.83 M)(11.25 M)(47.06 M)(40.49 M)(45.26 M)(48.84 M)
Operating Expenses42.45 M34.08 M48.71 M40.22 M46.94 M64.13 M
Operating Income(36.45 M)(11.93 M)(45.66 M)(38.5 M)(45.08 M)(48.64 M)
Revenues6 M22.15 M3.05 M1.72 M1.86 M1.91 M

Infinity Pharmaceuti Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Infinity Pharmaceuti. It measures of how well Infinity is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Infinity Pharmaceuti brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Infinity had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Infinity Pharmaceuti has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201720182019202020212022 (projected)
Capital Expenditure1.48 M707 K(2.33 M)(43 K)(11 K)(11.87 K)
Depreciation Amortization and Accretion1.72 M191 K219 K483 K480 K492.63 K
Net Cash Flow or Change in Cash and Cash Equivalents(41.13 M)14.01 M(26.04 M)6.33 M51.98 M56.08 M
Issuance Purchase of Equity Shares146 K9.62 M112 K7.87 M87.11 M93.98 M
Net Cash Flow from Financing(146 K)5.62 M27.73 M27.44 M87.11 M93.98 M
Net Cash Flow from Investing(4.28 M)13.1 M(12.24 M)14.63 M5.49 M6.15 M
Net Cash Flow Investment Acquisitions and Disposals(4.99 M)13.1 M(9.91 M)14.67 M5.5 M6.81 M
Net Cash Flow from Operations(36.71 M)(4.71 M)(41.53 M)(35.74 M)(40.62 M)(43.82 M)
Share Based Compensation6.97 M3.45 M2.13 M1.46 M2.69 M2.77 M

Infinity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuti's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuti competition to find correlations between indicators driving Infinity Pharmaceuti's intrinsic value. More Info.
Infinity Pharmaceuti is currently regarded as number one stock in net income category among related companies. It is currently regarded as number one stock in current liabilities category among related companies . Infinity Pharmaceuti Net Income is most likely to increase significantly in the upcoming years. The last year's value of Net Income was reported at (45.26 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value Infinity Pharmaceuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infinity Pharmaceuti's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Infinity Pharmaceuti's earnings, one of the primary drivers of an investment's value.

Infinity Pharmaceuti Systematic Risk

Infinity Pharmaceuti's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Infinity Pharmaceuti volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Infinity Pharmaceuti correlated with the market. If Beta is less than 0 Infinity Pharmaceuti generally moves in the opposite direction as compared to the market. If Infinity Pharmaceuti Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infinity Pharmaceuti is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infinity Pharmaceuti is generally in the same direction as the market. If Beta > 1 Infinity Pharmaceuti moves generally in the same direction as, but more than the movement of the benchmark.

About Infinity Pharmaceuti Financials

What exactly are Infinity Pharmaceuti Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Infinity Pharmaceuti's income statement, its balance sheet, and the statement of cash flows. Potential Infinity Pharmaceuti investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Infinity Pharmaceuti is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Infinity grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Infinity Pharmaceuti July 4, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Infinity Pharmaceuti help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Infinity Pharmaceuti. We use our internally-developed statistical techniques to arrive at the intrinsic value of Infinity Pharmaceuti based on widely used predictive technical indicators. In general, we focus on analyzing Infinity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Infinity Pharmaceuti's daily price indicators and compare them against related drivers.
Information Ratio(0.036917)
Maximum Drawdown40.94
Value At Risk(10.45)
Potential Upside13.89
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
52.6 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.